Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Peripheral Neuropathy: early-phase trial registry
5 of 18 indexed Diabetic Peripheral Neuropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 5 currently recruiting · #953 of 28,707 conditions by registered trial count
Diabetic Peripheral Neuropathy: 18 US clinical trials tracked, 5 recruiting.
Diabetic Peripheral Neuropathy is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Florida Institute for Human and Machine Cognition, running 2 of these trials.
Enrollment posture brief
Registry condition diabetic-peripheral-neuropathy
OPEN 5 | RECR 28% | LATE 2 | EARLY 4 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Neurofibromatosis Type 1 (28% recruiting · 18 trials)
Diabetic Peripheral Neuropathy lists 5 open slots (28% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Peripheral Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Peripheral Neuropathy is recruiting below its size-band peers.
5 of 18 indexed trials (27.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetic Peripheral Neuropathy trials is spread across many organizations.
Florida Institute for Human and Machine Cognition accounts for 2 of 18 trials (11.1%). 16 distinct sponsors appear on at least one study for this condition label.
-
Most Diabetic Peripheral Neuropathy trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 18 trials that report a genuine target (sentinel values excluded). 12 of those (66.7%) plan for fewer than 100 participants.
-
Diabetic Peripheral Neuropathy research is mostly interventional.
15 interventional and 3 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
Ohio State University
NCT06287736
Balance Control and Recovery in Diabetes Peripheral Neuropathy
Lisa Griffin
NCT06544876
Walking Function in Diabetic Peripheral Neuropathy
Florida Institute for Human and Machine Cognition
NCT05965336
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
Florida Institute for Human and Machine Cognition
NCT06591780
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
VA Office of Research and Development
NCT04658693
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
Novo Nordisk A/S
NCT06797869
A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT01041859
Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Daiichi Sankyo
NCT01496365
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain
Lexicon Pharmaceuticals
NCT04455633
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
Eliem Therapeutics (UK)
NCT04688671
Implementation of Telemedicine for Patient With Lower Extremity Wounds
University of California, Davis
NCT04440839
Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy
Orpyx Medical Technologies
NCT05613556
Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy
University of Michigan
NCT00835757
Corneal Nerves Function and Structure
VA Office of Research and Development
NCT04222660
Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy
Regenesis Biomedical
NCT03077893
The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy
Eastern Virginia Medical School
NCT02927951
Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN)
University of California, San Francisco
NCT02104466
Fall Risk Assessment in People With Diabetic Neuropathy
Stephen D. Jernigan, PT, PhD
NCT01040962
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Peripheral Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Peripheral Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Peripheral Neuropathy page
18 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Diabetic Peripheral Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Florida Institute for Human and Machine Cognition sponsors the most Diabetic Peripheral Neuropathy trials on record, review their full trial history before evaluating a specific study. See Florida Institute for Human and Machine Cognition's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Peripheral Neuropathy condition card totals 18 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.